Nordion announced it has signed a nonbinding letter of agreement with Best Medical International of Springfield, VA, for the divestiture of the Fleurus, Belgium, operations of MDS Nordion of Ottawa, Ontario.
The agreement for the divestiture will include three MDS Nordion lines of business, including the Glucotrace FDG imaging agent and the generic cyclotron and reactor isotope lines, and exclude the TheraSphere business, which will be retained by Nordion, the company announced.
Nordion expects that proceeds received for the divested operations will be nominal, and that it will leave sufficient working capital in the business to support its operations through an initial transition period.
During this process, MDS Nordion remains focused on continuing to deliver quality product to its customers and managing the business operations, the company said.
Best Medical designs, distributes, and manufactures radiation products for the oncology, urology, neurology, and gynecology markets.
Related Reading
MDS changes name, ticker symbols, October 27, 2010
MDS Nordion touts TheraSphere study, October 8, 2010
MDS inks Russian Mo-99 deal, September 23, 2010
MDS advances revenue in Q3, September 17, 2010
MDS extends cobalt-60 supply deal, August 13, 2000
Copyright © 2010 AuntMinnie.com
